How do I buy Olema Pharmaceuticals, Inc. Common Stock (OLMA) stock?

Buying Olema Pharmaceuticals, Inc. Common Stock (OLMA) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "OLMA", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy OLMA by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if OLMA is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Olema Pharmaceuticals, Inc. Common Stock (OLMA) Stock

Q: What is the minimum investment for OLMA on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Olema Pharmaceuticals, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · OLMA

Trade OLMA

Key stats

Market cap: $704.35M
Price / Earnings ratio: -2.7x
EPS (TTM): -$2.37
Volume: Loading
52-week high: $36.26
52-week low: $6.24

Source: third-party data provider, as of November 13, 2026

Compare with OLMA

Technical indicators

RSI 14: 56.14
MACD 12/26/9: -0.18
EMA 9 of MACD: -0.35
MACD histogram: 0.17
SMA 50: $8.31; Price below SMA 50
EMA 50: $8.23; Price below EMA 50
SMA 200: $13.26; Price below SMA 200
EMA 200: $13.89; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

0000

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

640M422M211M0

Revenue to Profit

2025

$0.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-162.5M

Net income

Earnings

No data available

Source: third-party data provider

About Olema Pharmaceuticals, Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees150

CEODr. Sean P. Bohen M.D., Ph.D.

IPO DateNov 19, 2020

HeadquartersSan Francisco, CA

Key Executives

Name	Title	Year Born
Dr. Sean P. Bohen M.D., Ph.D.	President, CEO & Director	1967
Mr. Jason O'Byrne M.B.A.	CFO, Principal Financial Officer & Accounting Officer	1969
Ms. Shawnte M. Mitchell J.D.	Chief Legal Officer & Corporate Secretary	1978
Dr. David C. Myles Ph.D.	Chief Scientific Officer	1963
Ms. Courtney O'Konek	Vice President of Corporate Communications	—
Ms. Julie Dexter	Senior VP & Head of People	—
Dr. Naseem Zojwalla M.D.	Chief Medical Officer	1973
Mr. Richard Hernandez	Senior Vice President of Clinical Development Operations	—
Dr. Mark Shilkrut M.D., Ph.D.	Senior Vice President of Clinical Development	—
Dr. Kamesh Kuchimanchi Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-66.7	-1.3
2022	-31.8	-33.3	-20.8	-37.8	+6.7	+45.4	+20.1	-20.2	-25.2	+29.2	-22.8	-14.0
2023	+83.0	-15.8	-13.5	+37.2	-4.8	+57.0	-1.3	+11.8	+16.4	+14.0	-6.6	-3.8
2024	-5.0	-18.7	-23.5	-6.6	-6.9	-8.0	+45.1	-28.3	+5.2	-6.3	-12.9	-42.9
2025	+9.7	-26.7	-10.7	+54.5	-0.2	-2.7	+17.6	+2.4	+51.3	-18.7	+236.3	-10.6
2026	+1.7	-5.7	-37.9	-4.7	-7.9	-1.6	-5.2	-7.5	-18.2	-15.4	+13.7

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Olema Pharmaceuticals, Inc. Common Stock (OLMA) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "OLMA", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy OLMA by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Olema Pharmaceuticals, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Olema Pharmaceuticals, Inc. Common Stock (OLMA) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track OLMA's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Olema Pharmaceuticals, Inc. Common Stock (OLMA) Stock

Key stats

Compare with OLMA

Recent news

4 Breast Cancer Stocks to Watch During Breast Cancer Awareness Month

4 Breast Cancer Stocks to Watch During Breast Cancer Awareness Month

Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study

Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

4 Breast Cancer Stocks to Watch During Breast Cancer Awareness Month

4 Breast Cancer Stocks to Watch During Breast Cancer Awareness Month

Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study

Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA

Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA

7 ‘Strong Buy' Biotech Stocks to Rejuvenate Your Portfolio

7 ‘Strong Buy' Biotech Stocks to Rejuvenate Your Portfolio

About Olema Pharmaceuticals, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade